CHERAMI logo

CHERAMI

Asia, Guangdong, China, Guangzhou

Description

CHERAMI is a private equity fund management firm.

Investor Profile

CHERAMI has backed more than 6 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Series B rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Medical, Health Care.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (50%)
  • Series C (17%)
  • Series B (17%)
  • Series Unknown (17%)

Country Focus

  • China (83%)
  • United States (17%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Oncology
  • Health Diagnostics
  • Biopharma
  • Energy
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CHERAMI frequently co-invest with?

Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Growth Capital Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Huagai Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
HM Capital
North America, Texas, United States, Dallas
Co-Investments: 1
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1
Pan-Lin Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by CHERAMI?

NeuShen Therapeutics

Shanghai, Shanghai, China

NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.

BiotechnologyMedical
Series AApr 18, 2025
MoleculeMind

Haidian, Beijing, China

MoleculeMind is an AI-integrated biotech firm that fuses artificial intelligence with biotechnology to form a new development platform.

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical
Series ASep 13, 2024
Amount Raised: $14,040,000
PVmed

Guangzhou, Guangdong, China

PVmed focuses the AI-enhanced auxiliary diagnosis and treatment.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMedical
Series ADec 22, 2022
Amount Raised: $14,000,000
Sinogen Biopharma

Boston, Massachusetts, United States

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BMay 23, 2022
Amount Raised: $10,000,000
GenFleet Therapeutics

Shanghai, Shanghai, China

GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.

BiotechnologyHealth CareOncologyPharmaceutical
Series CDec 31, 2021
Amount Raised: $78,667,065
Ronbay Technology

Yuyao, Zhejiang, China

Ronbay Technology is a manufacturer of cathode materials for power batteries.

EnergyManufacturing
Series UnknownJan 1, 2018